Louisiana State Employees Retirement System raised its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 18.7% during the third quarter, according to its most recent filing with the SEC. The firm owned 23,138 shares of the semiconductor company’s stock after purchasing an additional 3,638 shares during the period. Louisiana State Employees Retirement System’s holdings in Synopsys were worth $11,416,000 as of its most recent filing with the SEC.
Several other large investors also recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in Synopsys by 1.6% in the second quarter. Vanguard Group Inc. now owns 15,060,784 shares of the semiconductor company’s stock valued at $7,721,363,000 after buying an additional 231,014 shares during the period. State Street Corp raised its position in shares of Synopsys by 1.2% in the 2nd quarter. State Street Corp now owns 7,266,446 shares of the semiconductor company’s stock worth $3,725,362,000 after acquiring an additional 85,662 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Synopsys by 1.5% in the 2nd quarter. Geode Capital Management LLC now owns 3,545,892 shares of the semiconductor company’s stock worth $1,810,214,000 after acquiring an additional 51,043 shares in the last quarter. Ameriprise Financial Inc. lifted its stake in shares of Synopsys by 29.1% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock valued at $1,333,095,000 after purchasing an additional 585,494 shares during the period. Finally, Alliancebernstein L.P. boosted its position in shares of Synopsys by 10.9% during the 2nd quarter. Alliancebernstein L.P. now owns 1,913,001 shares of the semiconductor company’s stock valued at $980,757,000 after purchasing an additional 187,790 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities research analysts have weighed in on the company. KeyCorp lifted their target price on Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a report on Thursday, December 11th. Morgan Stanley raised their price objective on shares of Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. The Goldman Sachs Group lowered their price objective on shares of Synopsys from $700.00 to $600.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and cut their target price for the stock from $525.00 to $500.00 in a research note on Monday, December 8th. Finally, Wall Street Zen upgraded shares of Synopsys from a “sell” rating to a “hold” rating in a report on Saturday, December 13th. Eleven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Synopsys presently has an average rating of “Moderate Buy” and a consensus price target of $562.13.
Insider Activity at Synopsys
In other news, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.62% of the stock is currently owned by company insiders.
Synopsys Stock Up 3.0%
Synopsys stock opened at $508.77 on Wednesday. The firm has a market capitalization of $97.34 billion, a price-to-earnings ratio of 63.68, a price-to-earnings-growth ratio of 4.11 and a beta of 1.12. The firm’s fifty day moving average price is $440.92 and its two-hundred day moving average price is $503.83. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48.
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, topping the consensus estimate of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.25 billion. During the same period in the previous year, the firm posted $3.40 earnings per share. The firm’s revenue for the quarter was up 37.8% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, equities research analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- Punch these codes into your ordinary brokerage account
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
